Africa’s Premier
Medical Trade Event

Please click below for details

The 36th Medic Africa Exhibition

Our Publishing Partners

Below are details of our Publishing Partners for 2012. We are indebted to their commitment to the African health sector, through their support towards the publication of Africa Health throughout the year.

Our Publishing Partners are: Crown Agents, GlaxoSmithKline, Laureate International Universities, University of Liverpool, Medicine for Malaria Venture, Merck, sanofi aventis and Schiller.

Crown Agents is a leading international development firm that works with leaders across the world to make profound changes to systems, organisations and society. We provide professional and financial services to public sector and international organisations across the world, particularly focusing on health systems strengthening, fund and grant management, public financial management (especially revenue, debt and expenditure management) and public sector transformation. We have an extensive global footprint, with permanent offices in more than 20 countries and ongoing projects in over 100 countries. We work on the basis of long-term partnerships with our clients: national governments, non-governmental service providers, international agencies and donors.

With over 10 years’ experience online, the University of Liverpool, in partnership with Laureate International Universities, is the largest provider of 100% online postgraduate degrees in Europe, offering master’s and doctoral degrees in health, management, psychology, IT, law and education. The online Master of Public Health offers specialisations in International Public Health and Management of Health Systems.

University of Liverpool students stand out for their motivation and desire to make a difference. Of the total number of students, almost 40% come from Africa - a compliment to the number of students from this region who are seeking to "make a difference" through their profession and education.

Visit the website for information

Medicines for Malaria Venture (MMV) is recognized as the leading product development partnership (PDP) in the field of antimalarial drug research and development. It was established as a foundation in 1999 and registered in Switzerland. MMV’s mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs. MMV’s vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease.

Elizabeth Poll T +41 22 799 45 81 ................................................................................................
Medicines for Malaria Venture | MMV 20, route de Pré-Bois - PO Box 1826 1215 Geneva 15 – Switzerland

Sanofi is a diversified global healthcare leader, focused on patients’ needs. A world leader in human vaccines with a broad and balanced presence on both traditional and emerging markets, Sanofi has core strengths in the field of healthcare with its growth platforms in consumer healthcare, diabetes, innovative products and animal health. Through the acquisition of Geynzyme, Sanofi has reinforced its footprint in biotechnology and rare disease. The company has a staff complement of 727 staff in a variety of functions. Sanofi is committed to local manufacturing with a local production site in Waltloo, Pretoria, which manufactures and packages a wide range of pharmaceutical products. The factory is a global centre of excellence, producing TB drugs for the South African market and export to SADC countries and to key markets globally.. Some of the life-saving medicines manufactured and packed here include: anti-tuberculosis products, antibiotics and medicines for central nervous system disorders.

SCHILLER is one of the world's leading companies in the development, production and distribution of medical devices for cardiopulmonary diagnostics, patient monitoring and emergency medicine. Founded in 1974, SCHILLER has become known for its computerized ECG with automatic measurement and interpretation, defibrillators, as well as patient monitoring devices that are used all over the world and even in space (ISS). Distinguished by financial autonomy, continuous growth and innovations, the successful enterprise involves today more than 700 employees and an extensive distributional network worldwide. The Art of Diagnostics is boundless, infinitely creative and inspires SCHILLER to continuously improve its products. Howewer size is not as important to SCHILLER as is strength and the dedication to create long-term value for customers, patients and employees.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros. For further information please visit:

Latest issues

To read the issue click on a cover

Africa HealthAfrica Health

Back issues >>

Other titles

African Journal of Respiratory MedicineThe African Journal of Respiratory Medicine is the leading journal devoted exclusively to respiratory disease in the African region. visit AJRM >>

African Journal of Diabetes MedicineThe African Journal of Diabetes Medicine is the leading journal devoted exclusively to diabetes in the African region. visit AJDM >>